Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Syringomyelia Market Research By Type (Congenital, And Acquired), Diagnosis (CT Scan, MRI), Treatment (Monitoring, Chiari Surgery, Draining The Syrinx, Expansive Duraplasty, Surgical Removal of Cyst, Medication), End User ‚Äď Forecast Till 2030

ID: MRFR/MED/3802-HCR | 85 Pages | Author: Rahul Gotadki| May 2024

Syringomyelia Market Scenario

Syringomyelia Market is expected to grow USD 350 Million at a CAGR 6.80% during the forcast period 2023 to 2030.Syringomyelia is a chronic condition characterized by a fluid-filled cyst known as a syrinx that forms within the spinal cord. The syrinx can expand over time, and destroy the surrounding nerve tissue. There are several possible causes of syringomyelia but most cases are associated with Chiari malformation. Symptoms of syringomyelia may include pain, stiffness in the back, shoulders, neck, arms, or legs, progressive weakness in the arms and legs, headaches, imbalance, loss of bowel and bladder control, the curvature of the spine (scoliosis), numbness, or tingling.

There are majorly two forms of syringomyelia: congenital syringomyelia and acquired syringomyelia. The congenital syringomyelia is caused by a Chiari malformation, whereas causes of acquired syringomyelia include meningitis, spinal cord injury, a spinal cord tumor, arachnoiditis, tethered cord syndrome, and bleeding into the cord (hemorrhage).

According to the National Organization for rare diseases, syringomyelia is most commonly found in young adults between the ages of 20-40 years, but can also develop in young children or older adults. It is also reported that the condition is slightly more common in males than females.

Notably, rising need for the better treatment methods is the key factor driving the syringomyelia market growth. A number of scientist and researcher are continuously trying to find ways to halt or reverse the cell damage occurred due to spinal cord injury. Diagnostic technology is another area of continued research to better visualize conditions in the spine even before symptoms appear.

Various other factors such as increasing prevalence of syringomyelia, and related complications, increasing government assistance, improving regulatory framework, increasing awareness, and rising funding and reimbursement are continuously contributing to the growth of the syringomyelia market.

However, high treatment cost, injuries occurred because of treatment, and poor healthcare system in low and middle-income countries may hinder the growth of the market to an extent over the review period.

Key Players

Some of key the players in the syringomyelia market are Stryker, Medtronic Plc, Boston Scientific Corporation, B. Braun Melsungen AG, Johnson & Johnson Private Limited, CONMED Corporation, Novartis AG, Smith & Nephew PLC, Zimmer Holdings Inc., TransEnterix, Inc., Becton, Dickinson and Company, Aspen Surgical Products, Inc., Olympus Corp., Richard Wolf GmbH, Siemens Ltd., STORZ MEDICAL AG and others.

Intended Audience

  • Pharmaceutical Companies

  • Research and Development (R&D) Companies

  • Diagnostic Laboratories

  • Government Research Institute

  • Academic Institutes and Universities


The syringomyelia market is segmented on the basis of type, diagnosis, treatment, and end user.

On the basis of the type the syringomyelia market is classified as congenital syringomyelia (communicating syringomyelia) and acquired syringomyelia (noncommunicating syringomyelia).

On the basis of the diagnosis the syringomyelia market is classified as magnetic resonance imaging (MRI), computerized tomography (CT) scan, and others.

On the basis of the treatment the syringomyelia market is classified as monitoring, surgical care, and medication. The surgical care is further segmented into Chiari surgery, expansive duraplasty, surgical removal of the obstruction, draining the syrinx (shunt operation), and others. The medication is further segmented into analgesics, muscle relaxants, and others.

On the basis of the end user the syringomyelia market is segmented into hospitals, clinics, diagnostic centers, drug stores, pharmacies, and others.

Research Methodology Syringomyelia Market

Sources: Annual reports, Press release, White paper, and Company presentation

Regional Analysis

The Americas dominate the syringomyelia market owing to the rising awareness among people and high healthcare expenditure. According to the Centers for Disease Control and Prevention in 2015, the total health expenditure in the United States was reported to be USD 3.2 trillion and hospital care accounted for a share of 32.3%.

Europe holds the second position in the syringomyelia market. It is expected that the support provided by the government bodies for research & development and improvement in reimbursement policies in the healthcare is likely to drive the market of Europe region.

The Asia Pacific is the fastest growing syringomyelia market owing to a huge patient pool and developing healthcare technology. Healthcare expenditure is also improving in various Asia Pacific countries. According to the Australian Institute of Health and Welfare in the years 2015-2016, the total health expenditure was USD 170.4 billion, which is 3.6% higher than the expenditure of 2014-2015.

The Middle East & Africa holds the least share of the market due to lack of technical knowledge and poor medical facilities.

Report Attribute/Metric Details
  Market Size 350 Miilion
  CAGR 6.80% (2023-2030)
  Base Year 2022
  Forecast Period 2023-2030
  Historical Data 2021
  Forecast Units Value (USD Million)
  Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered Type, Diagnosis, Treatment, and End user
  Geographies Covered North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors Stryker, Medtronic Plc, Boston Scientific Corporation, B. Braun Melsungen AG, Johnson & Johnson Private Limited, CONMED Corporation, Novartis AG, Smith & Nephew PLC, Zimmer Holdings Inc., TransEnterix, Inc., Becton, Dickinson and Company, Aspen Surgical Products, Inc., Olympus Corp., Richard Wolf GmbH, Siemens Ltd., STORZ MEDICAL AG and others
  Key Market Opportunities Increasing prevalence of syringomyelia, and related complications Increasing government assistance Improving regulatory framework Increasing awareness Rising funding and reimbursement
  Key Market Drivers Rising need for the better treatment methods

Frequently Asked Questions (FAQ) :

Syringomyelia market is expected to expand at 6.80% CAGR from 2023 to 2030.

Increasing prevalence of syringomyelia and increased government assistance are primary drivers of the global syringomyelia market.

High costs of treatment, injuries associated with the treatment, and poor healthcare policies in low-income countries are major factors expected to impede the global syringomyelia market growth.

The Americas is expected to dominate the global syringomyelia market till 2023.

Johnson & Johnson Private Limited, TransEnterix, Inc., Richard Wolf GmbH, Olympus Corp., CONMED Corporation, Smith & Nephew PLC, Zimmer Holdings Inc., Medtronic Plc, Becton, Dickinson and Company, STORZ MEDICAL AG, Novartis AG, Boston Scientific Corporation, Stryker, B. Braun Melsungen AG, Aspen Surgical Products, Inc., and Siemens Ltd. are prominent players of the global syringomyelia market.

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.